Patient & Survivor Care
Latest News
Fear of Cancer Recurrence Can Persist for Childhood Survivors
Overall, 16.6% of adult survivors of childhood cancer reported clinically significant fear that their cancer would recur, and an additional 15.7%...
Latest News
Physician Empathy Mitigates Patients’ Chronic Pain
The extent of the physician’s empathy effects exceeded that reported for nonpharmacological treatments, current opioid use, and lumbar spine...
Latest News
Excess Body Weight Tied to Increased Risk for Second Cancers
For every 5-unit increase in BMI, the risk for an obesity-related cancer was considerably higher than the risk for any second cancer.
Commentary
What Should You Do When a Patient Asks for a PSA Test?
Prostate cancer is a leading cause of cancer death in males, but the Brazilian Ministry of Health recommends against population-based screening...
From the Journals
MMR/MSI Testing for CRC Climbs, But Variations Persist
To assess trends and factors associated with MMR/MSI testing, researchers evaluated 834,797 patients diagnosed with stage I to IV CRC between 2012...
Feature
Many Hurdles Exist to Treating Lung Cancer With CAR T Cells
Unleashing the immune system in a highly specific manner, ‘is obviously, in a way, a holy grail’ in lung cancer, said an expert at the W...
Feature
How to Treat Cancer While Preserving Fertility
Some chemotherapies are known for their effects on oocytes, follicle maturation, and spermatogenesis, but knowledge about newer treatment options...
Feature
The Biology of ‘Precancer’: Stopping Cancer Before It Starts
Why are some breast cancer types more likely to recur than others?
Commentary
Are Targeted Drugs the Future in Colorectal Cancer?
Preliminary results from three trials suggest some benefits of cetuximab plus irinotecan in patients who’d already had epidermal growth factor...
Conference Coverage
Adding Short-term ADT to High-Dose Radiotherapy Benefits Some Prostate Cancers
Patients with intermediate- or high-risk localized prostate cancer who had PSA levels under 30 ng/mL and no clinical involvement of the seminal...
Conference Coverage
IMRT vs Proton Therapy for Early Prostate Cancer?
The results of a new trial demonstrate ‘equivalent outcomes, with superb cancer control rates and extremely low toxicity from both treatments.’